6505--VALL Iodine Isotope IDIQ
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
262-NETWORK CONTRACT OFFICE 22 (36C262)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36C26226Q1309
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents2
The Department of Veterans Affairs (VA), through its 262-Network Contract Office 22, has issued a combined synopsis/solicitation as a Request for Information (RFI) and Sources Sought Notice for the anticipated procurement of radiopharmaceutical supplies, specifically Iodine I-123 isotopes, under an Indefinite Delivery Indefinite Quantity (IDIQ) contract. This notice, identified by procurement number 36C26226Q1309, is intended solely for information and planning purposes and does not constitute a formal solicitation or a request for proposal at this stage.
**Purpose and Scope**
The primary objective of this procurement is to establish a firm fixed-price IDIQ contract to supply radiopharmaceutical products—most notably Iodine I-123 (5 mCi per capsule)—to the VA Loma Linda Healthcare System (VALLHCS) located at 11201 Benton Street, Loma Linda, CA 92357. The contract is expected to cover a base period from October 1, 2026, through September 30, 2027, with four additional one-year option periods, potentially extending the contract through September 30, 2031. The supplies will support the Nuclear Medicine Section, Imaging Service, at the main hospital facility.
**Key Requirements and Deliverables**
The contractor will be responsible for providing Iodine I-123 capsules in specified quantities, with each line item representing 10 capsules per order, across multiple contract line items (CLINs) for each contract year. The contract will require both routine and emergency delivery capabilities: routine orders must be delivered by the next business day, while emergency orders require same-day delivery as specified at the time of order placement.
All radiopharmaceuticals must be packaged, marked, and transferred in compliance with all applicable local, state, and federal regulations, including those governing radioactive materials. Deliveries must include comprehensive documentation, such as packing lists, Material Safety Data Sheets (MSDS), and traceability information. The contractor must also provide waste disposal services for used radioactive materials at no additional charge, and ensure all products are bar-coded and compatible with the existing NMIS System.
Quality assurance is a critical component of this contract. The contractor must ensure that the radioactivity of supplied doses does not deviate beyond specified tolerances (+/-10% for therapeutic doses, +/-20% for imaging doses) and must perform all required quality control procedures in accordance with FDA, NRC, USP, and Joint Commission standards. The contractor must also provide technical support, including consultation, continuing education for technologists, and immediate notification and remediation in the event of recalls or quality issues.
**Contractor Qualifications and Compliance**
Contractors must be licensed by the State of Operation and the Nuclear Regulatory Commission or an Agreement State Agency. Pharmacists must be authorized users on the contractor’s Radioactive Materials License. Delivery personnel must be trained in radiation safety and comply with all relevant safety and transportation regulations. The contractor must also adhere to VA facility policies regarding security, personnel identification, parking, and smoking.
**Administrative and Security Considerations**
The contract will require monthly invoicing with detailed supporting documentation. No advance payments will be authorized. Contractors must comply with VA IT security requirements, including the protection of patient information and computer systems, and participate in any required system interconnection agreements.
**Classification and Set-Aside Information**
This opportunity is classified under NAICS code 325412 (Pharmaceutical Preparation Manufacturing), with a size standard of 1,300 employees, and Product Service Code 6505 (Drugs and Biologicals). The VA is seeking information from all qualified sources, including small businesses, Service-Disabled Veteran-Owned Small Businesses (SDVOSB), Veteran-Owned Small Businesses (VOSB), HUBZone, Woman-Owned Small Businesses (WOSB), and large businesses. Respondents are encouraged to provide details regarding their business size, capabilities, and compliance with subcontracting limitations and the Non-Manufacturer Rule, as applicable.
**Contact and Submission Information**
Interested parties should submit their responses, including a capabilities statement and answers to the specific questions outlined in the notice, via email to Hestia Sim at [email protected] no later than 10:00 AM Pacific Time on August 14, 2026. Telephone responses will not be accepted. All information received will be used for market research and planning purposes only and will not be considered as offers or proposals.
**Summary**
This RFI/Sources Sought Notice represents a significant opportunity for qualified suppliers of radiopharmaceuticals to support the VA’s mission of providing high-quality healthcare to veterans. Contractors with the requisite experience, regulatory compliance, and logistical capabilities are encouraged to respond and provide detailed information about their ability to meet the VA’s stringent requirements for the supply, delivery, and support of Iodine I-123 isotopes over a multi-year contract period.
For further details and to access the official notice, please refer to the SAM.gov posting at: https://sam.gov/opp/d0b9d6d66358479f8e1133515357dce4/view.